Suppr超能文献

评估药物与非平行浓度效应关系的相互作用的方法。

Method to Assess Interactivity of Drugs with Nonparallel Concentration Effect Relationships.

机构信息

The Ohio State University, Columbus, OH. United States.

Optimum Therapeutics, LLC, 1815 Aston Ave STE 107, Carlsbad, CA 92008. United States.

出版信息

Curr Cancer Drug Targets. 2017;17(8):735-755. doi: 10.2174/1568009617666170330154054.

Abstract

BACKGROUND

Commonly used methods for analyzing interactivity between drugs (e.g. synergy, antagonism) such as isobologram, combination index, and curve shift are based on the Loewe Additivity principle of dose equivalence and the inherent assumption of similar concentration- effect (C-E) including parallel curves and equal maximum effects (Emax), and therefore are not suitable for drugs with dissimilar C-E. This study describes a new method that is without this limitation and has the additional advantage of enabling statistical analysis.

METHODS AND RESULTS

The method comprises two steps. First, based on the dose equivalence principle, the experimentally obtained C-E of one drug was used to calculate the equally effective C-E of the other drug at no interactivity; the resulting two zero-interactivity C-E formed the upper and lower boundaries of Additivity Envelope. Next, 95% confidence intervals calculated from experimental data were added to Additivity Envelope to obtain Uncertainty Envelope (UE). Experimentally observed effects of drug combinations (C-Ecomb,observed) located within UE indicate additivity whereas C-Ecomb,observed located above or below UE indicate statistically significant (p<0.05) synergy or antagonism, respectively. Additional in silico studies demonstrated the shape and size of Additivity Envelope, which determines the ability to detect drug interactivity, depended on the Drug A-to-B concentration ratios and the ratios of their C-E curve shape parameter. Analyses of experimental results of combinations of drugs with nonparallel C-E and/or unequal Emax indicated UE as more versatile and provided more information, compared to earlier methods.

CONCLUSION

UE is a broadly applicable method for analysis, including statistical significance assessment, of drug interactivity.

摘要

背景

常用于分析药物相互作用(如协同作用、拮抗作用)的方法,如等效应线、合并指数和曲线移位,都是基于等效剂量的 Loewe 加和性原理和相似浓度-效应(C-E)的固有假设,包括平行曲线和平等最大效应(Emax),因此不适合具有不同 C-E 的药物。本研究描述了一种新方法,该方法没有这种限制,并且具有能够进行统计分析的额外优点。

方法和结果

该方法包括两个步骤。首先,基于等效剂量原理,用实验获得的一种药物的 C-E 来计算另一种药物在无相互作用时的等效 C-E;得到的两个零相互作用 C-E 形成加和性包络的上下限。接下来,用实验数据计算 95%置信区间并添加到加和性包络中,得到不确定性包络(UE)。位于 UE 内的药物组合的实验观察效应(C-Ecomb,observed)表明具有加和性,而位于 UE 之上或之下的 C-Ecomb,observed 则表示具有统计学意义(p<0.05)的协同作用或拮抗作用。额外的计算机模拟研究表明,加和性包络的形状和大小,决定了检测药物相互作用的能力,取决于药物 A 与 B 的浓度比及其 C-E 曲线形状参数比。对具有非平行 C-E 和/或不等 Emax 的药物组合的实验结果进行分析表明,与早期方法相比,UE 更通用,提供了更多信息。

结论

UE 是一种广泛适用于分析药物相互作用的方法,包括统计显著性评估。

相似文献

4
Parallel dose-response curves in combination experiments.联合实验中的平行剂量反应曲线。
Bull Math Biol. 1998 Mar;60(2):197-213. doi: 10.1006/bulm.1997.0009.
6
7
Assessment of non-linear combination effect terms for drug-drug interactions.药物相互作用的非线性组合效应项评估。
J Pharmacokinet Pharmacodyn. 2016 Oct;43(5):461-79. doi: 10.1007/s10928-016-9490-0. Epub 2016 Sep 16.
10
Drug Combinations: Tests and Analysis with Isoboles.药物组合:用等效线图进行测试与分析
Curr Protoc Pharmacol. 2016 Mar 18;72:9.19.1-9.19.19. doi: 10.1002/0471141755.ph0919s72.

引用本文的文献

本文引用的文献

2
What is synergy? The Saariselkä agreement revisited.什么是协同作用?重新审视萨利色尔卡协议。
Front Pharmacol. 2015 Sep 1;6:181. doi: 10.3389/fphar.2015.00181. eCollection 2015.
3
Analysis of drug combinations: current methodological landscape.药物联合分析:当前方法学全景。
Pharmacol Res Perspect. 2015 Jun;3(3):e00149. doi: 10.1002/prp2.149. Epub 2015 May 20.
7
Metformin targets ovarian cancer stem cells in vitro and in vivo.二甲双胍在体外和体内靶向卵巢癌细胞干细胞。
Gynecol Oncol. 2012 Nov;127(2):390-7. doi: 10.1016/j.ygyno.2012.07.115. Epub 2012 Aug 2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验